GlassScriptPhysician profile
Lowell Kabnick
NPI 1477533925
$1,364,337.77
in general payments reported to CMS, 2019-2025
7 companies · $134K in 2025
The $134K reported for 2025 was more than what 99% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $507K · 2020: $197K · 2021: $149K · 2022: $147K · 2023: $115K · 2024: $116K · 2025: $134K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $305K · Consulting Fee: $38K · Travel and Lodging: $15K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,850 · Food and Beverage: $2,229.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $304,813.32 |
| Consulting Fee | $38,312.50 |
| Travel and Lodging | $14,873.26 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,850.00 |
| Food and Beverage | $2,229.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $1,218,260.13 | 2019-2025 | Venacure 1470 Pro |
| Boston Scientific Corporation | $123,936.52 | 2019-2025 | Varithena Administration Pack, Ekosonic |
| Bard Peripheral Vascular, INC. | $21,442.80 | 2020-2025 | Venclose Maven Catheter, Venovo |
| Medtronic, INC. | $435.65 | 2021-2024 | Abre, Closurefast |
| Venclose INC. | $181.08 | 2019 | |
| Janssen Pharmaceuticals, INC | $54.58 | 2021-2022 | |
| Organogenesis INC. | $27.01 | 2023 | Puraply |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lowell Kabnick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.